264 related articles for article (PubMed ID: 6975729)
41. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
42. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
43. Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens.
Suthanthiran M; Gailiunas P; Person A; Fagan G; Strom TB; Carpenter CB; Garovoy MR
Transplant Proc; 1978 Jun; 10(2):471-3. PubMed ID: 354138
[No Abstract] [Full Text] [Related]
44. Shared antigenic determinants between human brain and human T-cell line.
Takada A; Takada Y; Ito U; Minowada J
Clin Exp Immunol; 1974 Dec; 18(4):491-8. PubMed ID: 4143285
[TBL] [Abstract][Full Text] [Related]
45. [Lymphocyte and cell-mediated immunity].
Cichocki T
Przegl Lek; 1972 Nov; 29(11):902-9. PubMed ID: 4540808
[No Abstract] [Full Text] [Related]
46. [Opioid peptides as regulators of the immune system].
Nasonov EL; Vinogradov VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):3-10. PubMed ID: 3300699
[No Abstract] [Full Text] [Related]
47. Production and diagnostic application of anti-human T-cell antisera.
Wick G; Ahmad R; Steiner R; Zeilinger M; Wolner E; Mittermayer K; Stacher A
Postgrad Med J; 1976; 52(5 Suppl):20-6. PubMed ID: 825844
[TBL] [Abstract][Full Text] [Related]
48. [Activity of B- and T-lymphocytes in selected skin diseases determined by the rosette formation and blast transformation tests].
Mosakowska-Glińska M
Ann Acad Med Stetin; 1979; 25():387-404. PubMed ID: 395866
[No Abstract] [Full Text] [Related]
49. Alloantibodies that react with subsets of human T cells.
van Leeuwen A
Tissue Antigens; 1979 Nov; 14(5):437-43. PubMed ID: 12731575
[TBL] [Abstract][Full Text] [Related]
50. [Microlymphocytotoxic test with T lymphocytes: positivity by 3 hrs incubation (author's transl)].
Májský A
Allerg Immunol (Leipz); 1978; 24(4):294-8. PubMed ID: 154291
[TBL] [Abstract][Full Text] [Related]
51. [Determination of the human T and B lymphocyte population using immunofluorescence and cytotoxicity tests with monoclonal antibodies].
Koubek K
Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):286-9. PubMed ID: 6215995
[No Abstract] [Full Text] [Related]
52. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
53. Activation of autologous reactive helper T lymphocytes for differentiation of human B lymphocytes.
Shin HS; Wang CY; Choi YS
J Immunol; 1981 Jun; 126(6):2485-9. PubMed ID: 7014720
[TBL] [Abstract][Full Text] [Related]
54. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
Broström H; Troye-Bomberg M; Perlmann P
Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
[TBL] [Abstract][Full Text] [Related]
55. Lymphocyte and granulocyte cytotoxic antibodies in cancer patients.
Laurentaci G; Favoino B
G Batteriol Virol Immunol; 1978; 71(7-12):148-57. PubMed ID: 549566
[TBL] [Abstract][Full Text] [Related]
56. [Antiglobulin rosette-forming tests for demonstrating surface lymphocyte membrane receptors].
Gencheva G; Koĭchev Ch
Eksp Med Morfol; 1983; 22(1):44-9. PubMed ID: 6360657
[No Abstract] [Full Text] [Related]
57. [Certain new methods of study of the lymphocyte function].
Vinogradova IuE; Grinshpun LD; Samoĭlova RS
Ter Arkh; 1974; 46(8):51-60. PubMed ID: 4609165
[No Abstract] [Full Text] [Related]
58. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
59. [Immunologic reactivity of the body in sarcoidosis patients].
Chernushenko EF; Goncharova SI; Kogosova LS
Klin Med (Mosk); 1983 Dec; 61(12):44-9. PubMed ID: 6608033
[No Abstract] [Full Text] [Related]
60. Uptake of antilymphocyte globulin by human peripheral lymphocytes.
Brain P; Marston RH
Clin Exp Immunol; 1973 Mar; 13(3):423-6. PubMed ID: 4633851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
